Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Bill· SS. 757 (116th)referred
United States · United States Congress · 12 March 2019
Petroleum Coke Transparency and Public Health Protection Act This bill requires the Department of Health and Human Services (HHS) to study and report on petroleum coke usage, including public-health and environmental impacts, best practices for storage and transport, and an analysis of current and projected production and utilization locations. The Environmental Protection Agency must issue rules for petroleum coke storage and transportation that protect public and ecological health, based on the HHS study.
Bill· SS. 753 (116th)referred
United States · United States Congress · 12 March 2019
Improving Access to Medicare Coverage Act of 2019 This bill deems an individual receiving outpatient observation services in a hospital as an inpatient for purposes of satisfying the three-day inpatient hospital-stay requirement with respect to Medicare coverage of skilled nursing facility services.
Bill· SS. 741 (116th)referred
United States · United States Congress · 12 March 2019
Cancer Drug Parity Act of 2019 This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration. To comply with this requirement, health plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.
Bill· SS. 740 (116th)referred
United States · United States Congress · 12 March 2019
Alzheimer's Caregiver Support Act This bill authorizes the Department of Health and Human Services to award grants to public and nonprofit private health care providers to expand training and support services for families and caregivers of individuals living with Alzheimer's disease or a related dementia.
Resolution· SRESS.Res. 105 (116th)passed
United States · United States Congress · 12 March 2019
This resolution expresses support for the designation of March 2019 as National Colorectal Cancer Awareness Month.
Bill· HRH.R. 1675 (116th)referred
United States · United States Congress · 11 March 2019
Petroleum Coke Transparency and Public Health Protection Act This bill requires the Department of Health and Human Services (HHS) to study and report on petroleum coke usage, including public-health and environmental impacts, best practices for storage and transport, and an analysis of current and projected production and utilization locations. The Environmental Protection Agency must issue rules for petroleum coke storage and transportation that protect public and ecological health, based on the HHS study.
Bill· HRH.R. 1667 (116th)referred
United States · United States Congress · 11 March 2019
Preventing Doomsday Act This bill directs the Department of Transportation to publish a report that explains (1) its contingency plan that details a specific plan of action in the case of a shutdown of a rail track in the North River Tunnel underneath the Hudson River and that addresses issues including ensuring commuters, tourists, and others will maintain the ability to travel between New Jersey and New York and throughout the region; and (2) its contingency plan detailing a specific plan of action to ensure minimal disruption to, and negative impact on, national security, the economy, public health, the environment, and property values.
Resolution· HRESH.Res. 209 (116th)referred
United States · United States Congress · 11 March 2019
This resolution declares support for Brain Awareness Week and calls upon Americans to recognize and support brain and spinal-cord research.
Resolution· SRESS.Res. 103 (116th)passed
United States · United States Congress · 11 March 2019
This resolution supports the designation of National Assistive Technology Awareness Day. It also commends assistive technology specialists, program coordinators, organizations, and researchers for their assistance in helping people with disabilities to access such technology.
Bill· HRH.R. 1646 (116th)referred
United States · United States Congress · 8 March 2019
Helping Emergency Responders Overcome Act of 2019 or the HERO Act of 2019 This bill establishes a series of programs relating to the behavioral health of public-safety officers (e.g., law-enforcement officers, firefighters, ambulance crew members, and 9-1-1 operators). For example, the bill establishes (1) a public-safety officer suicide-reporting system at the Centers for Disease Control and Prevention, and (2) a grant program for peer-support behavioral health and wellness programs within fire departments and emergency medical services agencies.
Bill· HRH.R. 1647 (116th)reported
United States · United States Congress · 8 March 2019
Veterans Equal Access Act This bill directs the Department of Veterans Affairs (VA) to authorize VA health care providers to (1) provide veterans with recommendations and opinions regarding participation in their state's marijuana programs, and (2) complete forms reflecting such recommendations and opinions.
Bill· HRH.R. 1643 (116th)referred
United States · United States Congress · 8 March 2019
PrEP Assistance Program Act This bill requires the Department of Health and Human Services to establish a grant program that supports pre-exposure prophylaxis (PrEP) programs in states, U.S. territories, and Indian tribes. PrEP is a method of HIV prevention in which high-risk individuals take daily medications to reduce the chance of infection.
Bill· HRH.R. 1659 (116th)referred
United States · United States Congress · 8 March 2019
Disaster Preparedness for Power Outages Act of 2019 This bill authorizes the Department of Health and Human Services to award grants to long-term care facilities to help such facilities prepare for power outages during and after natural disasters. Eligible grant activities include the purchase of backup power sources (e.g., generators) and the creation of regional resource directories.
Bill· HRH.R. 1657 (116th)referred
United States · United States Congress · 8 March 2019
Seniors' Health Care Choice Act of 2019 This bill creates a special Medicare enrollment period for individuals enrolled in, or transitioning out of, continuation coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA)—a federal law that allows an individual to maintain health coverage following loss of coverage due to termination of employment or another qualifying event.
Bill· HRH.R. 1656 (116th)referred
United States · United States Congress · 8 March 2019
Strengthening our Pediatric Workforce Act of 2019 This bill authorizes the Health Resources and Services Administration to provide grants to children's hospitals with graduate residency programs that are located in health-professional shortage areas. Such grants are used to develop initiatives addressing pediatric health disparities, including access to care, poverty, opioid overuse, food insecurity, and child abuse.
Report· HearingH.Hrg.116published
United States · United States House of Representatives · 7 March 2019
Bill· HRH.R. 1589 (116th)open
United States · United States Congress · 7 March 2019
CBRN Intelligence and Information Sharing Act of 2019 This bill expands the functions of the Office of Intelligence and Analysis of the Department of Homeland Security related to homeland-security focused intelligence and information sharing. The office shall support intelligence analysis and risk assessment of terrorist actors, their claims, and their plans to conduct attacks involving chemical, biological, radiological, and nuclear materials against the United States; support intelligence analysis and risk assessment of global infectious disease, public health, food, agricultural, and veterinary issues; and share information and provide tailored analytical support on these threats to state, local, tribal, and territorial authorities and to relevant national biosecurity and biodefense stakeholders and other federal agencies.
Bill· HRH.R. 1587 (116th)referred
United States · United States Congress · 7 March 2019
Marijuana Data Collection Act This bill requires the Department of Health and Human Services, in coordination with the Department of Justice, the Department of Labor, and relevant state agencies, to enter into an arrangement with the National Academy of Sciences in order to study the effects of marijuana legalization in states for medicinal or non-medicinal use.
Bill· HRH.R. 1597 (116th)referred
United States · United States Congress · 7 March 2019
National Nurse Act of 2019 This bill requires the Department of Health and Human Services to designate the Chief Nurse Officer of the Public Health Service as the National Nurse for Public Health. The position includes the authority to (1) provide leadership and coordination of Public Health Service nursing professional affairs for the Office of the Surgeon General and other agencies of the Public Health Service, (2) conduct outreach and education, and (3) provide guidance and leadership for activities that will increase public safety and emergency preparedness. The National Nurse for Public Health must (1) participate in identification of national health priorities, (2) encourage volunteerism of nurses and strengthen the relationship between government agencies and health-related national organizations, and (3) promote the dissemination of evidence-based practice in educating the public on health promotion and disease prevention activities.
Bill· HRH.R. 1584 (116th)referred
United States · United States Congress · 7 March 2019
Energy Sovereignty Act This bill repeals the requirement that states must revise implementation plans to prevent or eliminate air pollution endangering public health or welfare in other countries when directed to do so by the Environmental Protection Agency.
Bill· HRH.R. 1581 (116th)referred
United States · United States Congress · 7 March 2019
Reproductive Rights are Human Rights Act of 2019 This bill directs the Department of State to include in its annual reports on human rights in countries receiving U.S. development and security assistance a discussion of the status of reproductive rights in each country, including whether a country has adopted and enforced policies to (1) promote access to contraception and accurate family planning information, (2) provide services to ensure safe and healthy pregnancy and childbirth, (3) expand or restrict access to safe abortion services, (4) prevent maternal deaths, and (5) prevent and treat sexually transmitted diseases. For each country, the reports shall also contain (1) data related to maternal deaths, and (2) a description of the nature and extent of discrimination and violence against women and girls in health care settings and the relevant government's response to such actions.
Resolution· HRESH.Res. 188 (116th)referred
United States · United States Congress · 7 March 2019
This resolution expresses support for the designation of National Sarcoma Awareness Month.
Bill· SS. 726 (116th)referred
United States · United States Congress · 7 March 2019
Personal Care Products Safety Act This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.
Bill· SS. 709 (116th)referred
United States · United States Congress · 7 March 2019
Prescription Drug Pricing Dashboard Act This bill requires the Department of Health and Human Services to establish an online dashboard containing information about the prices and utilization of prescription drugs that are purchased by federal programs. The dashboard must include specified information, including spending per dosage, the number of drug recipients, and out-of-pocket costs. The dashboard must also highlight those drugs that have the highest spending and costs.
Bill· SS. 707 (116th)referred
United States · United States Congress · 7 March 2019
Reproductive Rights are Human Rights Act of 2019 This bill directs the Department of State to include in its annual reports on human rights in countries receiving U.S. development and security assistance a discussion of the status of reproductive rights in each country, including whether a country has adopted and enforced policies to (1) promote access to contraception and accurate family planning information, (2) provide services to ensure safe and healthy pregnancy and childbirth, (3) expand or restrict access to safe abortion services, (4) prevent maternal deaths, and (5) prevent and treat sexually transmitted diseases. For each country, the reports shall also contain (1) data related to maternal deaths, and (2) a description of the nature and extent of discrimination and violence against women and girls in health care settings and the relevant government's response to such actions.
Bill· SS. 696 (116th)referred
United States · United States Congress · 7 March 2019
National Nurse Act of 2019 This bill requires the Department of Health and Human Services to designate the Chief Nurse Officer of the Public Health Service as the National Nurse for Public Health. The position includes the authority to (1) provide leadership and coordination of Public Health Service nursing professional affairs for the Office of the Surgeon General and other agencies of the Public Health Service, (2) conduct outreach and education, and (3) provide guidance and leadership for activities that will increase public safety and emergency preparedness. The National Nurse for Public Health must (1) participate in identification of national health priorities, (2) encourage volunteerism of nurses and strengthen the relationship between government agencies and health-related national organizations, and (3) promote the dissemination of evidence-based practice in educating the public on health promotion and disease prevention activities.
Bill· SS. 691 (116th)referred
United States · United States Congress · 7 March 2019
Medicare Extra Rx Higher Eligibility Limits in Part D Act of 2019 or the Medicare Extra Rx HELP Act of 2019 This bill expands eligibility for certain premium subsidies for low-income beneficiaries under the Medicare prescription drug benefit. Specifically, the bill raises the maximum allowable income for beneficiaries to qualify from 135% to 200% of the federal poverty line.
Report· HearingH.Hrg.116published
United States · United States House of Representatives · 6 March 2019
Bill· HRH.R. 1570 (116th)referred
United States · United States Congress · 6 March 2019
Removing Barriers to Colorectal Cancer Screening Act of 2019 This bill waives Medicare coinsurance requirements with respect to colorectal cancer screening tests, regardless of the code billed for a resulting diagnosis or procedure.
Resolution· HRESH.Res. 180 (116th)open
United States · United States Congress · 6 March 2019
This resolution expresses support for the goals and ideals of National Colorectal Cancer Awareness Month.
Bill· HRH.R. 1564 (116th)referred
United States · United States Congress · 6 March 2019
Outpatient Mental Health Modernization Act of 2019 This bill includes nutritional planning, meals, and transportation, as well as vocational and employment counseling services, as covered partial-hospitalization services under Medicare. The Department of Health and Human Services shall convene a Behavioral Health Advisory Committee to address specified issues, including discrimination against the chronically mentally ill, elderly, and veterans in relation to treatment for mental illness.
Bill· HRH.R. 1559 (116th)referred
United States · United States Congress · 6 March 2019
340B Protection and Accountability Act of 2019 This bill makes various changes to the 340B prescription drug pricing program, including requiring certain participants to pay annual user fees and requiring certain participants to establish sliding scales for the amounts they charge low-income individuals for outpatient drugs.
Bill· HRH.R. 1551 (116th)referred
United States · United States Congress · 6 March 2019
Quality Care for Moms and Babies Act This bill directs the Centers for Medicare & Medicaid Services (CMS) to take a series of actions relating to the quality of maternal and infant care under Medicaid, the Children's Health Insurance Program (CHIP), and other health programs. Specifically, the CMS must identify and publish a recommended core set of maternal and infant quality measures for women and children, as specified by the bill; publish an initial core set of any such measures applicable to mothers and infants eligible under Medicaid or CHIP; establish a Maternal and Infant Quality Measurement Program; and establish an online clearinghouse of resources for entities working to improve maternity and infant care quality. The CMS may also make grants to eligible entities (e.g., state Medicaid programs, health departments, and provider organizations) to develop or expand maternity and infant care quality collaboratives or initiatives.
Resolution· HRESH.Res. 181 (116th)referred
United States · United States Congress · 6 March 2019
This resolution supports the designation of National Bartter Syndrome Day. (Bartter syndrome is caused by genetic defects that affect kidney function. Symptoms include muscle weakness and growth delay.)
Bill· SS. 684 (116th)referred
United States · United States Congress · 6 March 2019
Middle Class Health Benefits Tax Repeal Act of 201 9 This bill repeals the excise tax on employer-sponsored health care coverage for which there is an excess benefit (high-cost plans). The repeal applies to taxable years beginning after December 31, 2019.
Bill· SS. 668 (116th)referred
United States · United States Congress · 6 March 2019
Removing Barriers to Colorectal Cancer Screening Act of 2019 This bill waives Medicare coinsurance requirements with respect to colorectal cancer screening tests, regardless of the code billed for a resulting diagnosis or procedure.
Law· HRH.R. 1503 (116th)enacted
United States · United States Congress · 5 March 2019
Orange Book Transparency Act of 2019 This bill modifies requirements for the Food and Drug Administration (FDA) to list and publish drug patent and exclusivity information. Specifically, the FDA must include on its list certain patent information and must specify each drug exclusivity period that has not concluded. The holder of an approved drug application must notify the FDA when a listed patent is invalidated by a court or by the Patent Trial and Appeal Board. The FDA must remove invalidated patents from its list, subject to the 180-day drug exclusivity period.
Bill· HRH.R. 1499 (116th)open
United States · United States Congress · 5 March 2019
Protecting Consumer Access to Generic Drugs Act of 2019 This bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product. Specifically, such an agreement shall, with some exceptions, be a violation of the bill if the filer of a subsequent application to market a drug or biological product receives anything of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the subsequent drug or biological product. (Typically, a subsequent application seeks to market a generic or biosimilar version of a patented drug or biological product.) Penalties for violations of the bill include civil penalties and loss of the 180-day exclusivity period for a generic drug. The Federal Trade Commission (FTC) shall have exclusive authority to litigate to enforce the bill. When a generic or biosimilar drug manufacturer enters into an agreement with another drug manufacturer related to the manufacturing, marketing or sale of a drug, the manufacturers must certify that the material they have given the FTC concerning the agreement contains (1) the complete agreement; and (2) any agreements related to the main agreement, including descriptions of any oral agreements or representations.
Bill· HRH.R. 1506 (116th)referred
United States · United States Congress · 5 March 2019
Fair And Immediate Release of Generic Drugs Act or the FAIR Generics Act This bill disqualifies from being a first applicant an applicant submitting a generic drug application to the Food and Drug Administration if the applicant has entered into a specified disqualifying agreement. Currently, any generic drug applicant submitting an application on the first day an application is submitted for that drug is a first applicant and is granted a 180-day marketing exclusivity period. A disqualifying agreement is an agreement between the applicant and the holder of the application or a patent for the brand-name drug whereby the applicant agrees not to seek approval or begin marketing the generic drug until the expiration of the exclusivity period awarded to another applicant. The bill expands the definition of first applicant to include applicants that did not submit an application on the first day an application was submitted. To be included, these first applicants must not have a patent infringement action pending against them and must not have been found to have infringed a patent. If an applicant that submitted an application on the first day an application was submitted has begun marketing the drug, a first applicant that submitted after the first day may not begin marketing until 30 days after the first-day applicant began marketing. A first applicant that has entered into an agreement to not seek approval of an application or begin marketing at the earliest possible date may not seek approval or begin marketing until the earlier of (1) the latest date set forth in the agreement, or (2) 180 days after a first day applicant begins marketing.
Bill· HRH.R. 1533 (116th)referred
United States · United States Congress · 5 March 2019
Improving Access to Mental Health Act This bill increases the Medicare reimbursement rate for clinical social worker services. The bill excludes clinical social worker services from the prospective payment system in which predetermined amounts form the basis for payment under Medicare. Additionally, the bill alters the definition of clinical social worker services as it relates to Medicare. Under current law, such services (1) include services performed for the diagnosis and treatment of mental illnesses, and (2) exclude services furnished to an inpatient of a skilled nursing facility as a condition of the facility's participation in the Medicare program. The bill repeals these provisions and instead specifies that such services include certain types of health behavior assessment and intervention.
Bill· HRH.R. 1530 (116th)referred
United States · United States Congress · 5 March 2019
Treat and Reduce Obesity Act of 2019 This bill expands Medicare coverage of intensive behavioral therapy for obesity. Specifically, the bill allows coverage for therapy that is provided by (1) a physician who is not a primary care physician; or (2) other health care providers (e.g., physician assistants and nurse practitioners) and approved counseling programs, if provided upon a referral from, and in coordination with, a physician or primary care practitioner. Currently, such therapy is covered only if provided by a primary care practitioner. The bill also allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.
Bill· HRH.R. 1518 (116th)referred
United States · United States Congress · 5 March 2019
Medicare Hearing Aid Coverage Act of 2019 This bill expands Medicare coverage to include hearing aids and related examinations. The Government Accountability Office must study programs that provide assistance for hearing aids and related examinations for individuals with hearing loss.
Bill· HRH.R. 1517 (116th)referred
United States · United States Congress · 5 March 2019
Connecting Opportunities through Mobility Metric and Unlocking Transportation Efficiencies Act or the COMMUTE Act This bill directs the Department of Transportation to carry out an accessibility data pilot program. The purpose of the pilot program is to develop or make available an accessibility data set for states and metropolitan or rural planning organizations to improve their transportation planning by measuring the level of access to important destinations such as jobs, health care facilities, child care services, educational and workforce training facilities, affordable housing, and food sources.
Bill· HRH.R. 1510 (116th)referred
United States · United States Congress · 5 March 2019
Premium Relief Act of 201 9 This bill establishes and provides funding through FY2022 for the Patient and State Stability Fund, which shall be used to support specified state efforts to increase access to health-insurance coverage and help stabilize the individual market. Specifically, states may use the funds to (1) lower the cost for individuals to purchase coverage, (2) lower out-of-pocket costs for individuals with insurance, (3) pay health care providers, (4) cover or provide additional specified services, and (5) otherwise increase coverage options and stabilize premiums in the state's insurance market. If a state does not apply for funds under the program, the Centers for Medicare & Medicaid Services, in consultation with the state, must use the funds to stabilize premiums by partially reimbursing insurers for claims in a specified cost range. The bill also revises the grace period that health insurers must provide to recipients of premium subsidies before discontinuing health coverage for nonpayment of premiums. The grace period is shortened from 3 months to 30 days unless state law includes an applicable grace period.
Bill· HRH.R. 1498 (116th)referred
United States · United States Congress · 5 March 2019
Stopping Appealing Flavors in E-Cigarettes for Kids Act or the SAFE Kids Act This bill generally prohibits the inclusion of flavored products in non-cigarette tobacco products, including electronic nicotine delivery system (e.g., e-cigarettes and vape pens).
Resolution· HRESH.Res. 179 (116th)referred
United States · United States Congress · 5 March 2019
This resolution commends the international community, health organizations, the private sector, school and community leaders, and faith-based organizations for bolstering health through vaccination. It also recognizes that the lack of vaccination can create an environment in which a public health crisis could emerge, and that there is no credible evidence that vaccines cause life-threatening or disabling diseases in healthy children or adults. The resolution also encourages a continued commitment to vaccine research, and urges everyone to follow the scientific evidence and consensus of medical experts in favor of timely vaccinations.
Bill· SS. 660 (116th)referred
United States · United States Congress · 5 March 2019
Efficiency and Transparency in Petitions Act This bill requires a petition regarding a pending generic drug or biological product application to be submitted to the Food and Drug Administration (FDA) within one year of when the petitioner discovers the issue that is the basis for the petition. The FDA may grant a waiver of the one-year deadline.
Bill· SS. 658 (116th)referred
United States · United States Congress · 5 March 2019
Accelerated Drug Approval for Prescription Therapies Act or the ADAPT Act This bill authorizes the Food and Drug Administration (FDA) to create an expedited drug approval process specifically for drugs that are currently approved for sale in certain countries (i.e., a European Economic Area member country, Australia, Canada, Israel, Japan, New Zealand, South Africa, or Switzerland) and meet certain criteria. Such criteria shall include establishing that (1) the drug is safe and effective, (2) all relevant U.S. patents or legal exclusivities have expired, and (3) the United States has a public health or unmet medical need for the drug. The FDA must process and review an application under this bill within 180 days of submission.
Bill· SS. 657 (116th)referred
United States · United States Congress · 5 March 2019
This bill prohibits health insurers and contracted entities that provide pharmacy benefits management services from receiving a price reduction or other remuneration from prescription drug manufacturers. The prohibition does not apply if (1) the price reduction is reflected at the point-of-sale; and (2) the other remuneration is a transparent, flat service fee that the manufacturer pays in relation to pharmacy benefits management services.
Bill· SS. 655 (116th)referred
United States · United States Congress · 5 March 2019
Stopping Appealing Flavors in E-Cigarettes for Kids Act or the SAFE Kids Act This bill generally prohibits the inclusion of flavored products in non-cigarette tobacco products, including electronic nicotine delivery system (e.g., e-cigarettes and vape pens).
PreviousPage 23 of 24Next